Perrigo Company plc (NYSE:PRGO) Declares Quarterly Dividend of $0.29

Perrigo Company plc (NYSE:PRGO) declared a quarterly dividend on Thursday, July 30th. Shareholders of record on Friday, August 28th will be paid a dividend of 0.29 per share on Tuesday, September 15th. This represents a c) annualized dividend and a yield of 11.2%. The ex-dividend date of this dividend is Friday, August 28th.

Perrigo has increased its dividend payment by an average of 0.1%annually over the last three years and has increased its dividend every year for the last 23 years. Perrigo has a payout ratio of 35.5% meaning its dividend is sufficiently covered by earnings. Research analysts expect Perrigo to earn $2.40 per share next year, which means the company should continue to be able to cover its $1.16 annual dividend with an expected future payout ratio of 48.3%.

Perrigo Trading Down 0.6%

Shares of PRGO stock traded down $0.07 during trading hours on Thursday, hitting $10.36. 2,696,142 shares of the company’s stock traded hands, compared to its average volume of 3,187,603. The company has a quick ratio of 1.59, a current ratio of 2.72 and a debt-to-equity ratio of 1.45. Perrigo has a 12 month low of $9.23 and a 12 month high of $27.33. The stock has a market cap of $1.43 billion, a PE ratio of -0.79, a price-to-earnings-growth ratio of 1.22 and a beta of 0.51. The stock’s 50 day simple moving average is $10.57 and its 200 day simple moving average is $11.68.

Perrigo (NYSE:PRGO) last posted its quarterly earnings data on Wednesday, May 6th. The company reported $0.43 earnings per share for the quarter, beating analysts’ consensus estimates of $0.39 by $0.04. The business had revenue of $841.80 million during the quarter, compared to the consensus estimate of $1.04 billion. Perrigo had a positive return on equity of 9.96% and a negative net margin of 43.50%.Perrigo’s quarterly revenue was down 7.2% on a year-over-year basis. During the same period in the prior year, the business posted $0.60 earnings per share. Perrigo has set its FY 2026 guidance at 2.250-2.550 EPS. On average, sell-side analysts anticipate that Perrigo will post 2.11 EPS for the current year.

Perrigo Company Profile

Perrigo Company plc is a global healthcare supplier specializing in over-the-counter (OTC) and self-care products, as well as generic prescription pharmaceuticals and active pharmaceutical ingredients. The company develops, manufactures and distributes a broad array of consumer health products, including analgesics, vitamins and supplements, digestive health remedies, topical treatments, and infant formulas. Perrigo’s focus on private-label solutions has made it a leading partner for retailers and pharmacy chains seeking high-quality, value-oriented alternatives to branded medications and health supplements.

Organized across three principal business segments—Consumer Healthcare, Prescription Pharmaceuticals and Active Pharmaceutical Ingredients—Perrigo’s operations span research and development, manufacturing, quality assurance and global distribution.